Very nice article, bull. Good to know we own 14.5% of this company that is positioning itself for the multitude of applications for Cell-in-a-Box(R) technology.
And eventhogh they mention many partners, only one is named on their website, Nuvilex. Interesting to note they also mention the upcoming trials 1Q 2015 for pancreatic cancer.